M&A Deal Summary |
|
|---|---|
| Date | 2011-11-22 |
| Target | Caris Life Sciences - Anatomic Pathology Business |
| Sector | Life Science |
| Buyer(s) | Miraca Holdings |
| Sellers(s) | Caris Diagnostics |
| Deal Type | Divestiture |
| Deal Value | 725M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Miraca Holdings, Inc. is engaged in the business consisting of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2011) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-22 |
Inform Diagnostics
Irving, Texas, United States Inform Diagnostics is a provider of anatomic pathology services primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Inform Diagnostics continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities, and close relationships with clinical partners. Inform Diagnostics was formed in 1996 and is based in Irving, Texas. |
Sell | - |
Caris Diagnostics, Inc. is a pathology company specializing in gastrointestinal pathology, dermatopathology, hematopathology and urologic pathology services.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2011) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
